Skip to main content

Month: September 2025

Fengate expands healthcare infrastructure portfolio with acquisition of 24 U.S. outpatient facilities

MIAMI, Sept. 11, 2025 (GLOBE NEWSWIRE) — Fengate Asset Management (Fengate) is pleased to announce the acquisition of a portfolio of 24 medical outpatient facilities from a top United States (U.S.) healthcare system under a sale-leaseback agreement. The facilities, located across two states, add more than 900,000 square feet of medical space to Fengate’s growing healthcare portfolio. The firm has been investing in social infrastructure since 2006 and manages more than 55 healthcare assets across the U.S. and Canada. “Fengate is proud to partner with one of the largest and strongest not-for-profit health systems in the U.S. on this transaction alongside our partner, MedCraft,” said Mac Bell, Managing Director, Head of Social and Transportation at Fengate. The transaction is the first acquisition by the Fengate-MedCraft joint venture. “We...

Continue reading

SAP Completes Acquisition of SmartRecruiters, Delivering Innovation and AI-Powered Recruiting Differentiation for Global Enterprises

SAN FRANCISCO, Sept. 11, 2025 (GLOBE NEWSWIRE) —  SAP SE (NYSE: SAP) today announced it has completed the acquisition of SmartRecruiters, the Recruiting AI Company. Together, SAP and SmartRecruiters will accelerate innovation in talent acquisition while giving customers confidence, flexibility, scale, and the only platform built to meet the full spectrum of enterprise hiring needs, helping organizations attract, engage, and hire top talent. Innovation at Speed With SAP’s global scale and SmartRecruiters’ category-defining platform, customers can expect faster delivery of AI-powered capabilities, end-to-end orchestrated talent solutions, and user experiences that directly support business outcomes. The combined roadmap will accelerate innovation across candidate engagement, recruiter efficiency, and hiring manager experience. One-of-a-Kind...

Continue reading

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

RA’ANANA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company“), a pioneer in innovative life-support and diagnostic technologies, today announced pivotal results for its HYLA blood sensor, achieving 97.35% accuracy in its latest performance testing phase that will support its upcoming U.S. Food and Drug Administration (“FDA”) submission. These results represent a significant advancement from the initial data obtained in a clinical study, as announced on March 4, 2025. The clinical study from March, conducted at a medical center ranked among the world’s leading hospitals, provided validation for HYLA’s performance, while these latest test results confirm the device’s readiness for the regulatory...

Continue reading

LiveOne (Nasdaq: LVO) Restarted $12 Million Stock Buyback Program

• Repurchased 5M+ shares• $5.9M remaining in program• Senior Management and Directors, led By Robert Ellin, Chairman and CEO, to purchase up to 5M shares LOS ANGELES, Sept. 11, 2025 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, today announced an update on its previously authorized $12 million stock repurchase program. “We believe our stock remains significantly undervalued, and this commitment reflects our strong confidence in LiveOne’s growth trajectory and long-term value,” said Robert Ellin, Chairman and CEO of LiveOne. About LiveOneHeadquartered in Los Angeles, CA, LiveOne (Nasdaq: LVO) is an award-winning, creator-first, music, entertainment, and technology platform focused on delivering premium experiences and content worldwide through memberships...

Continue reading

Form 8.3 – [IQE PLC – 10 09 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today highlighted positive efficacy data from its Phase 2 clinical trial, THIO-101, evaluating ateganosine (THIO) sequenced with the immune checkpoint inhibitor (CPI) cemiplimab (Libtayo®) in patients with advanced non-small cell lung cancer (NSCLC) who had failed two or more standard-of-care therapy regimens. As of June 30, 2025,Estimated median progression free survival (PFS) in third-line treatment (180 mg dose) was 5.6 months. The comparable PFS threshold in standard of care treatments is 2.5 months1. Estimated median overall survival (OS) was 17.8 months, with a 95% confidence interval (CI) lower bound of 12.5...

Continue reading

YY Group Announces Amendment to $4 Million Registered Direct Offering

Singapore, Sept. 11, 2025 (GLOBE NEWSWIRE) — YY Group Holding Limited (Nasdaq: YYGH) (“YY Group” or the “Company”) today announced the amendment of its previously announced registered direct offering. The Company and the investors have entered into an amended and restated securities purchase agreement, pursuant to which the Company will offer 9,523,812 Class A Ordinary shares and warrants to purchase up to 14,285,718 Class A Ordinary Shares at a purchase price of $0.42 per share and accompanying warrants. The warrants have an exercise price of $0.50 per share and a 3.5-year term. Gross proceeds to the Company are expected to be approximately $4.0 million, assuming no exercise of the warrants, before deducting offering expenses. The Company expects to use the net proceeds from this offering for working capital and general corporate...

Continue reading

MACOM Supports PCIe and CXL Connectivity Over Optical Fiber with High Performance Chipset

LOWELL, Mass., Sept. 11, 2025 (GLOBE NEWSWIRE) — MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, today announced the availability of a new chipset to overcome the distance limitations of traditional PCI Express (PCIe) and Compute Express Link (CXL) connectivity by enabling high speed, low latency communication over optical fiber. Designed to maintain signal integrity and reduce latency, the chipset consists of the MATA-38794 transimpedance amplifier (TIA) and the MALD-38795 VCSEL driver. By consolidating sideband signaling into a single fiber pair, MACOM’s solution reduces the cost and complexity of optical transceivers and cabling. As data centers and high-performance computing environments demand increasing bandwidth and reach, MACOM’s chipset enables PCIe extension up to 100 meters over...

Continue reading

Partners Value Split Corp. Announces Completion of US$100,000,000 Public Offering of Class AA Preferred Shares, Series 16

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES TORONTO, Sept. 11, 2025 (GLOBE NEWSWIRE) — Partners Value Split Corp. (the “Company”) announced today the completion of its previously announced offering of Class AA Preferred Shares, Series 16 (the “Series 16 Preferred Shares”). A total of 4,000,000 Series 16 Preferred Shares were issued at an offering price of US$25.00 per Series 16 Preferred Share, raising gross proceeds of US$100,000,000. The issuance included 1,000,000 Series 16 Preferred Shares issued pursuant to the exercise, in full, of the underwriters’ option granted by the Company to the underwriters in the offering. The Series 16 Preferred Shares carry quarterly fixed cumulative preferential dividends representing a 5.40% annualized yield on the offering price and have a final maturity...

Continue reading

NeoVolta Unveils Its 250kW / 430kWh Commercial & Industrial BESS at RE+ 2025; Availability Beginning in Q4 2025

SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV), a U.S.-based energy technology company delivering scalable storage, for resilient residential and commercial power infrastructure, today unveiled its first Commercial & Industrial (C&I) energy storage solution: the 250kW / 430kWh battery energy storage system (BESS). The new product can be seen at the company’s booth, no. V12313, at RE+ 2025 in Las Vegas. The NeoVolta C&I BESS is designed to deliver powerful, scalable energy management for commercial properties, industrial sites, and microgrid applications. Built with the same safety-first approach and installer-centered design as NeoVolta’s residential systems, the C&I BESS offers businesses a path to energy independence, demand charge reduction, and backup power resilience. Key features...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.